Evidence map›Paper›PMID 27296645›Full record

ArticleeLife2016

A new synthetic biology approach allows transfer of an entire metabolic pathway from a medicinal plant to a biomass crop.

Paulina Fuentes, Fei Zhou, Alexander Erban, Daniel Karcher, Joachim Kopka, Ralph Bock

Abstract read
In one paragraph

Article in eLife, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. EngineeringFrontiers in plant science · 2024
    Article
  15. Article
  16. Metabolic Pathway Engineering Improves Dendrobine Production inInternational journal of molecular sciences · 2023
    Article
  17. Plastid engineering using episomal DNA.Plant cell reports · 2023
    Review
  18. Review
  19. Article
  20. De Novo Hybrid Assembled Draft Genome ofLife (Basel, Switzerland) · 2023
    Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Paulina FuentesMax-Planck-Institut für Molekulare Pflanzenphysiologie, Potsdam-Golm, Germany.
Fei ZhouMax-Planck-Institut für Molekulare Pflanzenphysiologie, Potsdam-Golm, Germany.
Alexander ErbanMax-Planck-Institut für Molekulare Pflanzenphysiologie, Potsdam-Golm, Germany.
Daniel KarcherMax-Planck-Institut für Molekulare Pflanzenphysiologie, Potsdam-Golm, Germany.
Joachim KopkaMax-Planck-Institut für Molekulare Pflanzenphysiologie, Potsdam-Golm, Germany.
Ralph BockMax-Planck-Institut für Molekulare Pflanzenphysiologie, Potsdam-Golm, Germany.ORCID 0000-0001-7502-6940

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artemisinin-based therapies are the only effective treatment for malaria, the most devastating disease in human history. To meet the growing demand for artemisinin and make it accessible to the poorest, an inexpensive and rapidly scalable production platform is urgently needed. Here we have developed a new synthetic biology approach, combinatorial supertransformation of transplastomic recipient lines (COSTREL), and applied it to introduce the complete pathway for artemisinic acid, the precursor of artemisinin, into the high-biomass crop tobacco. We first introduced the core pathway of artemisinic acid biosynthesis into the chloroplast genome. The transplastomic plants were then combinatorially supertransformed with cassettes for all additional enzymes known to affect flux through the artemisinin pathway. By screening large populations of COSTREL lines, we isolated plants that produce more than 120 milligram artemisinic acid per kilogram biomass. Our work provides an efficient strategy for engineering complex biochemical pathways into plants and optimizing the metabolic output.

Indexed as

AntimalarialsArtemisininsMetabolic EngineeringMetabolic Networks and PathwaysMolecular BiologyNicotianaPlants, Genetically ModifiedPlants, MedicinalSynthetic BiologyAntimalarialsartemisic acidArtemisininsartemisininbiochemistrycombinatorial transformationmetabolic engineeringNicotiana tabacumplant biologyplastid transformationsynthetic biology

Identifiers

PMID27296645
PMCPMC4907697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.